The Peptide Report
An evidence-first answer to whether NAD+ nasal spray actually produces measurable cellular and cognitive effects. We break down bioavailability research, realistic timelines, and how to separate science from marketing hype.
Intranasal NAD+ and IV infusions both aim to raise cellular NAD+ — but they differ sharply in cost, convenience, and consistency. Here's how the two delivery methods actually compare in 2026.
